Skip to Main Content

Paper Details

HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer.
Nat Genet
30
2022
AR, G84E, HDAC3, HOXB13, HOXB13 G84E mutation, HOXB13 gene, PCa, PCa cells, androgen, androgen receptor, androgen-dependent prostate cancer, fatty acid, fatty acid synthase, histone, histone deacetylase, homeodomain, homeodomain transcription factor, human, lipogenic enhancers, prostate cancer, tumor
Author NameAffiliation
Sylvan C BacaDana-Farber Cancer Institute
Colm MorrisseyUniversity of Washington
Eva CoreyUniversity of Washington
Matthew L FreedmanDana-Farber Cancer Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
Matthew L FreedmanDana-Farber Cancer Institute
Matthew L FreedmanCenter for Functional Cancer Epigenetics, Dana-Farber Cancer Institute
  • 1 - 7

Datasets

Release 1.2